Hospitals

Comprehensive Care + 24 Hour Emergency

Evaluating a New Drug Combination for Dogs with Lymphoma

Canine
Yellow lab in a field

Lymphoma is a devastating disease that can affect all species and sometimes treatment options are limited. Currently new drugs are being investigated that would aid in the treatment of lymphoma which would expand the options for owners.

ELIGIBILITY: Dogs with lymphoma receiving treatment at the Cornell University Hospital for Animals are eligible.

COMPENSATION: All study drugs will be provided at no cost. All other costs will be the responsibility of the owner.

OWNER RESPONSIBILITIES: You will be given the new drug combination to try at home until the cancer worsens. Your dog will return to the Cornell University Hopsital for Animals after beginning the trial for recheck visits weekly for four weeks, and then every two to four weeks based on the discretion of the treating oncologist. This schedule may be changed based on how your dog is feeling. A fine needle aspirate of an affected lymph node may be obtained at each visit after beginning the trial. In addition, blood will be drawn at each of the first four visits. After that, the frequency of blood sampling will be based on how your dog is tolerating the medications.

CONTACT/SCHEDULE AN APPOINTMENT: Please call the clinical trials coordinator at 607.253.3060, or email vet-research@cornell.edu